# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Nov 29, 2023

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2023-11-29
- Accepted by EDGAR: Nov 29, 2023, 16:10 ET
- Period: 2023-11-29
- Accession: 0001628280-23-040222
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000162828023040222/arwr-20231129.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000162828023040222/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000162828023040222/arwr-20231129.htm

Filed Nov 29, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-040222. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.